Limax Biosciences
Skip to content
Limax Biosciences

Student i-lab

Limax Biosciences

Treating internal and external injuries with a stretchable adhesive hydrogel.

About Limax Biosciences

Term

2023 Summer

School

Non-Harvard Affiliate, Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard Medical School

Connect

Website

Limax Biosciences is developing a next generation, stretchable hydrogel-based tissue adhesive to revolutionize treatments for injuries inside and outside the body. Existing hemostatic dressings and sealants have weak tissue adhesion that result in leaks, tissue rigidity, and cytotoxicity. Limax’s degradable, hydrogel-based material addresses these limitations through strong and rapid adhesion to wet tissue surfaces at 10-100x higher the strength of competitors. This patent-protected platform technology can be used in several indications throughout the body including soft tissue reinforcement and local drug delivery.

Join Us

Current Harvard students: submit your spring membership form by Thursday, January 9.

Students at a networking event